Your browser doesn't support javascript.
loading
Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation.
Nicot, Arnaud B; Harb, Jean; Garcia, Alexandra; Guillot, Flora; Mai, Hoa-Le; Mathé, Camille V; Morille, Jérémy; Vallino, Amélie; Dugast, Emilie; Shah, Sita P; Lefrère, Fabienne; Moyon, Mélinda; Wiertlewski, Sandrine; Le Berre, Ludmilla; Renaudin, Karine; Soulillou, Jean-Paul; van Pesch, Vincent; Brouard, Sophie; Berthelot, Laureline; Laplaud, David-Axel.
Afiliación
  • Nicot AB; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Harb J; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Garcia A; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Guillot F; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Mai HL; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Mathé CV; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Morille J; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Vallino A; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Dugast E; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Shah SP; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Lefrère F; Service de Neurologie, CHU Nantes, Nantes 44000, France.
  • Moyon M; CIC Inserm 1413, CHU Nantes, Nantes 44000, France.
  • Wiertlewski S; Service de Neurologie, CHU Nantes, Nantes 44000, France.
  • Le Berre L; CIC Inserm 1413, CHU Nantes, Nantes 44000, France.
  • Renaudin K; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Soulillou JP; Service de Neurologie, CHU Nantes, Nantes 44000, France.
  • van Pesch V; CIC Inserm 1413, CHU Nantes, Nantes 44000, France.
  • Brouard S; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Berthelot L; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
  • Laplaud DA; INSERM, Nantes Université, CHU Nantes, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes 44000, France.
Brain Commun ; 5(2): fcad044, 2023.
Article en En | MEDLINE | ID: mdl-36910419

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Commun Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Commun Año: 2023 Tipo del documento: Article País de afiliación: Francia